Now accepting applications for the Georgia CTSA TL1 (T32-like) Training Grant Clinical & Translational Research Training - Predoc Due February 17, Postdoc Due March 16

Accepting Applications for the Georgia CTSA TL1 (T32-like) TRAINING GRANT



Register for the free TL1 Application Workshop December 11, 2019 at 9:30 a.m. – see below.


Applicants to the Georgia Clinical & Translational Science Alliance (Georgia CTSA) TL1 program must be from one of the four Georgia CTSA institutions: Emory, Georgia Tech, Morehouse School of Medicine, or University of Georgia. Per NIH requirements, TL1 applicants must be U.S. Citizens or Permanent Residents.

The Georgia CTSA, the NIH-supported Clinical and Translational Science Award TL1 program (, is focused on providing innovative didactic and mentored research training to individuals interested in careers that encompass clinical and/or translational research. The TL1 program provides an opportunity to complete the Master of Science in Clinical Research or the Certificate Program in Translational Research. The TL1 program supports predoctoral and postdoctoral trainees (medical and PhD students, resident and fellow physicians, PhD postdocs, and PharmD residents).   

Applicants admitted into the TL1 program receive the following:    

  • Stipend: One year of predoctoral or postdoctoral stipend support and health insurance based on the NIH NRSA scale.
  • Tuition: Tuition support for the Emory or Morehouse School of Medicine MSCR program (MSCR coursework begins August 2020). 
  • Travel: A total of $1,000 is provided to each TL1 awardee for travel to the Translational Science Scientific Meeting in Washington, D.C in April 2020 to present their research findings

Predoctoral TL1 program eligibility:

  • Medical students: Medical students at Emory or Morehouse School of Medicine are eligible for TL1 support as part of a dual degree (MD/MSCR) track. Medical student applicants accepted into the TL1 program begin TL1 support and the MSCR program after their year of clinical rotations (i.e., generally after their 3rd year of medical school).
  • PhD graduate students or PharmD students: PhD-level graduate students or Pharm D students may apply for TL1 support to begin the program in the year after passing comprehensive examinations. The TL1 support would provide opportunities to receive dual degrees (PhD/MSCR track or PharmD/MSCR).

Postdoctoral TL1 program eligibility:

  • Physicians in Training (residents and fellows): Postdoctoral physicians, including senior residents and those in fellowship training programs at the Emory University School of Medicine, may apply to the TL1 program at any point in their postdoctoral (residency or fellowship) training.
  • Postdoctoral fellows with PhD, PharmD, or equivalent degrees: PhD postdoctoral fellows and PharmD residents may apply at any point in their postdoctoral training.

For more information on how to apply to the TL1 program and the application requirements, please see the program’s website, 

Free Workshop: December 11, 2019, 9:30-11:30. To register, e-mail Dr. Janet Gross ( and Cheryl Sroka ( Include: name, position, department, school, title of research study (if known), mentor/sponsor, and NIH Biosketch (preferable) or CV. 

Applicants to the TL1 program are highly encouraged but not required to attend this workshop, which will also be live streamed.

Emory: Cheryl Sroka -; 404.727.5096
MSM: Dr. Douglas Paulsen –; 404.752-1559
Georgia Tech:  Dr. Pamela Bhatti –; 734-216-3327
UGA: Dr. Som Shenoy –; 706-721-4250


Upcoming Events

    View All Events

    Latest News


    Georgia CTSA at UGA: Henry Young, PhD Improving Medication Use & Enhancing Care Communication

    In 2013, Henry Young, PhD joined the University of Georgia (UGA) as the Kroger Associate Professor in Community Pharmacy. For the Georgia Clinical & Translational Science Alliance (Georgia CTSA) he is a co-director of the Integrating Special...